Neurologic disorders affect millions of people worldwide and impose a significant burden on patients, caregivers, and healthcare systems. Although new treatments are urgently needed, and lots of progress has been achieved by neurological research efforts, still the development of novel therapies is hindered by limits in understanding individual neurologic diseases and challenges in conducting clinical research.
Advances in biotechnology are deepening understanding of the pathology of neurologic diseases and creating novel mechanisms for treatment and evaluation. To improve the process of drug development, academic centers, government agencies, and industrial representatives are collaborating to establish centralized systems for clinical trial design and data coordination.
In addition, advances in electronic data capture and dissemination are helping investigators to make faster, better informed decisions regarding a drug’s clinical potential.